Revenue
2022
2023
2024
2025
OnKure Therapeutics, Inc. (OKUR)
Price$3.58Cached quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — |
| Research & development | $48.3M | $43.8M | $32.1M | $37.7M | $28.2M | $15.9M |
| Operating expenses | $63.0M | $54.4M | $36.9M | $53.8M | $39.8M | $19.6M |
| Operating income | −$63.0M | −$54.4M | −$36.9M | −$53.8M | −$39.8M | −$19.6M |
| EBITDA | −$62.5M | −$53.9M | −$36.5M | −$53.8M | −$39.8M | −$19.5M |
| Net income | −$59.5M | −$52.7M | −$35.3M | −$52.0M | −$39.8M | −$19.5M |
| Basic EPSper basic share | -$4.40 | -$15.28 | -$124.41 | -$21.20 | -$21.90 | -$96.00 |
| Diluted EPSper diluted share | -$4.40 | -$15.28 | -$124.41 | -$21.20 | -$21.90 | -$96.00 |
Owners
Reported shareholders
9.87%of listed shares
RA CAPITAL MANAGEMENT, L.P.4M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
RA CAPITAL MANAGEMENT, L.P. | 9.87%4M shares |
BVF INC/IL | 7.99%3.24M shares |
ACORN CAPITAL ADVISORS GP, LLC / ACORN BIOVENTURES, L.P. / Hove Anders D | ≈7.01%2.84M shares |
ACORN CAPITAL ADVISORS, LLC | 7.01%2.84M shares |
StepStone Group LP | 6.57%2.66M shares |
ADAR1 Capital Management, LLC | 5.53%2.24M shares |
Vivo Capital, LLC | 4.76%1.93M shares |
Vestal Point Capital, LP | 4.51%1.83M shares |
BlackRock, Inc. | 3.70%1.5M shares |
Trails Edge Capital Partners, LP | 3.55%1.44M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.55%1.44M shares |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.98%1.2M shares |
CITADEL ADVISORS LLC | 2.93%1.19M shares |
Acorn Capital Advisors GP 2, LLC / ACORN BIOVENTURES 2, L.P. | ≈2.79%1.13M shares |
Sio Capital Management, LLC | 2.66%1.08M shares |
Prosight Management, LP | 2.42%978.99K shares |
Logos Global Management LP | 2.38%963.86K shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.79%724.44K shares |
NEA Management Company, LLC | 1.18%478.55K shares |
STATE STREET CORP | 1.14%463.66K shares |
Percentages use 40.5M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 22, 2026Form 4 | Leverone Jason A.Chief Financial Officer | SellClass A Common Stock | 303 | $4.40 | $1.3K | 18.8K |
| Jun 22, 2026Form 4 | Saccomano Nicholas APresident and CEO | SellClass A Common Stock | 86 | $4.40 | $378.40 | 11.2K |
| Mar 23, 2026Form 4 | Leverone Jason A.Chief Financial Officer | SellClass A Common Stock | 301 | $4.16 | $1.3K | 16.0K |
| Mar 23, 2026Form 4 | Saccomano Nicholas APresident and CEO | SellClass A Common Stock | 86 | $4.16 | $357.76 | 7.3K |
| Dec 22, 2025Form 4 | Leverone Jason A.Chief Financial Officer | SellClass A Common Stock | 302 | $2.97 | $896.94 | 16.3K |